The prevalence of gestational diabetes in advanced economies

Schneider, Sven; Böck, Christina; Wetzel, Marion; Maul, Holger; Loerbroks, Adrian

doi:10.1515/jpm-2012-0015

Cited by 120 publications

(88 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our finding of 8.3% GDM among Rwandan women is largely comparable with data from developed countries: 3.2-7.6% in the US and 2.0-11.6% in Europe, (Schneider et al 2012) as well as data from Africa: 4.5%-13.4% in Nigeria, (Anzaku & Musa 2013) 3.7% in Ethiopia (Seyoum et al 1999) and 3.8-8.8% in South Africa . (Mamabolo et al 2007).…”

Section: Discussionsupporting

confidence: 87%

Strategy to improve the burden of gestational diabetes in African women: Rwandan perspective

Mapira¹,

Tumusiime²,

Yarasheski³

et al. 2017

RWJour

View full text Add to dashboard Cite

The global prevalence of gestational diabetes (GDM) in pregnant 20-49 year old women has increased to 16.9%, although data from Africa on GDM are scarce, and risk exposure to pregnant women is unknown. Among the 288 pregnant women screened in Rwanda, 8.3% of women with FPG >126 mg/dL (>6.9 mmol/L) had GDM. Age >41 years (45.8% vs. 18.9%; p<0.001), first-family history of T2D (29.2% vs. 3.4%; p<0.001) and gravidity ≥3 pregnancies (79.2% vs. 29.2%; p=0.05) were associated with GDM. Gestational diabetes is a high risk factor for T2D, and increases the risk to T2D for women and their offspring later in life. Thus, improving maternal and child cardiometabolic health in Africa is needed through integrated gestational diabetes screening, and cost-effective sustainable strategies to build healthcare staff capacity, and to prioritize relevant evidence-based research and healthcare.

show abstract

Section: Discussionsupporting

confidence: 87%

Strategy to improve the burden of gestational diabetes in African women: Rwandan perspective

Mapira¹,

Tumusiime²,

Yarasheski³

et al. 2017

RWJour

View full text Add to dashboard Cite

show abstract

“…Perhaps the most important of these was the observed increase in GDM prevalence, especially when applied universally. 5,6 This led other bodies to maintain the previous two-step diagnostic and screening procedures. 1 In 2013, the World Health Organization (WHO) recommended the IADPSG criteria, 1 although it warned of possible difficulties in implementing them.…”

Section: Introductionmentioning

confidence: 99%

Clinical characteristics of women with gestational diabetes - comparison of two cohorts enrolled 20 years apart in southern Brazil

et al. 2017

View full text Add to dashboard Cite

CONTEXT AND OBJECTIVE: The prevalence and characteristics of gestational diabetes mellitus (GDM) have changed over time, reflecting the nutritional transition and changes in diagnostic criteria. We aimed to evaluate characteristics of women with GDM over a 20-year interval. DESIGN AND SETTING: Comparison of two pregnancy cohorts enrolled in different periods, in university hospitals in Porto Alegre, Brazil: 1991 to 1993 and 2009 to 2013 (n = 375). METHODS:We applied two diagnostic criteria to the cohorts: International Association of Diabetes and Pregnancy Study Groups (IADPSG)/World Health Organization (WHO); and National Institute for Health and Care Excellence (NICE). We compared maternal-fetal characteristics and outcomes between the cohorts and within each cohort. RESULTS:The women in the 2010s cohort were older (31 ± 7 versus 30 ± 6 years), more frequently obese (29.4% versus 15.2%), with more hypertensive disorders (14.1% versus 5.6%) and at increased risk of cesarean section (adjusted relative risk 1.8; 95% confidence interval: 1.4 -2.3), compared with those in the 1990s cohort. Neonatal outcomes such as birth weight category and hypoglycemia were similar. In the 1990s cohort, women only fulfilling IADPSG/WHO or only fulfilling NICE criteria had similar characteristics and outcomes; in the 2010s cohort, women only diagnosed through IADPSG/WHO were more frequently obese than those diagnosed only through NICE (33 ± 8 kg/m 2 versus 28 ± 6 kg/m 2 ; P < 0.001). CONCLUSION: The epidemic of obesity seems to have modified the profile of women with GDM. Despite similar neonatal outcomes, there were differences in the intensity of treatment over time. The IADPSG/ WHO criteria seemed to identify a profile more associated with obesity. RESUMO

show abstract

“…The prevalence of GDM varies between populations, ranging from 1.7% to 11.6% [1]. Numerous studies found that GDM is associated with significantly higher maternal (cesarean section, gestational hypertension, preeclampsia), perinatal (macrosomia and birth injury) and postnatal (early onset of metabolic syndrome, diabetes and hypertension in children) complications risk [2,3].…”

Section: Introductionmentioning

confidence: 99%

First and third trimester serum concentrations of adropin and copeptin in gestational diabetes mellitus and normal pregnancy

Dąbrowski

Jarmużek²,

Gondek³

et al. 2016

Ginekol Pol

View full text Add to dashboard Cite

Objectives: Gestational diabetes mellitus (GDM) is a metabolic disease diagnosed in 1.7% up to 11.6% pregnancies. The prevalence of adverse pregnancy outcome is significantly higher in the case of early onset of diabetes mellitus. Adropin is a hormone promoting carbohydrate oxidation over fat oxidation, and influence nitric oxide synthase. Copeptin is a cleavage product of the vasopressin precursor recently correlated with diabetes mellitus. The aim of the study was to determine maternal serum adropin and copeptin concentrations in women with early and late manifestation of GDM and to discuss their potential role as biochemical markers of insulin resistance. Material and methods:Case-control study on 58 pregnant Caucasian women. Serum levels of adropin and copeptin were assessed in patients with early onset (GDM1) and classical gestational diabetes mellitus (GDM2). Complications such as macrosomia and hypotrophy were evaluated. Results:There was no significant difference between the study and the control group (age, BMI, parity). Fetal growth disturbance rate was 37.5% in GDM1, 11% in GDM2 and 6% in controls. Adropin concentration in GDM patients was significantly higher than in control group (p < 0.001), but there was no difference between GDM1 and GDM2 group. High serum concentration of adropin positively correlated with elevated HbA 1c (p < 0.05). The groups did not differ in terms of copeptin serum concentration. Conclusions:High adropin serum concentration in GDM patients is associated with increased risk of fetal growth disturbances, possibly due to improper placentation. According to our prospective study, neither copeptin nor adropin serum concentration are useful to discriminate between early and late onset of gestational diabetes mellitus.

show abstract

The prevalence of gestational diabetes in advanced economies

Abstract: This review provides a comprehensive and sound summary of the current state of research on the prevalence of GDM in advances economies as a fi rst step in identifying starting points for future interventions.

Cited by 120 publications

References 27 publications

Strategy to improve the burden of gestational diabetes in African women: Rwandan perspective

Strategy to improve the burden of gestational diabetes in African women: Rwandan perspective

Clinical characteristics of women with gestational diabetes - comparison of two cohorts enrolled 20 years apart in southern Brazil

First and third trimester serum concentrations of adropin and copeptin in gestational diabetes mellitus and normal pregnancy

Contact Info

Product

Resources

About